International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICRTET-4
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 5
September-October 2026
Indexing Partners
Correlation of PON1 rs662 gene polymorphism, Serum Paraoxonase 1 and Calprotectin levels in Chronic Kidney Disease patients in Northern India
| Author(s) | Dr. SHUBHAM SINGH CHAUHAN, Dr. VANDANA SAINI, Dr. HIMANSHU VERMA, Dr. CHETNA BHATOTIYA, Dr. ALKA RAMTEKE |
|---|---|
| Country | India |
| Abstract | Introduction: Chronic Kidney Disease (CKD) is a gradually progressing non-communicable disease, resulting in the identification of patients in many later stages. PON1 levels are affected by the rs662 gene, which may play a significant role in the pathogenesis of CKD. Calprotectin is a novel inflammatory biomarker that may provide better insight into the progression of the disease. The aim of the present study was to identify the association of PON1 rs662 gene polymorphism with the levels of serum PON1 and serum calprotectin in patients with CKD. Methods: A case-control study was undertaken in a tertiary care hospital in Northern India with 240 participants, with 120 belonging to the case group and 120 to the control group. Venous blood sampling was performed, and the centrifuged serum sample was used for running an ELISA test for PON1, and genotyping was performed using whole blood. Serum gel electrophoresis was performed. Analysis of data was done by using SPSS, version 25.0. Statistical significance was considered with a p-value < 0.05. Results: The serum PON1 level was significantly lower in the CKD group than in the controls (858.69 ± 168.27 vs 1259.03 ± 333.96 ng/mL; p<0.0001). Logistic regression analysis showed that the homozygous GG genotype of PON1 rs662 SNP had a nearly 5-fold increased risk of developing CKD (OR =4.75, 95% CI 2.06-10.89, p < 0.01). Serum Calprotectin was significantly higher in the CKD group than in the control group (346.50±65.56 vs 315.93±48.15 ng/mL, p < 0.05). Conclusion: The homozygous GG genotype of PON1 rs662 gene polymorphism was significantly associated with increased CKD susceptibility. Serum PON1 and calprotectin levels may become potential predictive determinants to assist in early intervention and assess the severity of CKD. |
| Keywords | Chronic Kidney Disease, Polymorphism, Paraoxonase 1, Calprotectin |
| Field | Biology > Genetics / Molecular |
| Published In | Volume 8, Issue 5, September-October 2026 |
| Published On | 2026-09-26 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals